The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Immunoinformatics and Vaccine Development: An Overview
Open accessAbstract
The use of vaccines have resulted in a remarkable improvement in global health. It has saved several lives, reduced treatment costs and raised the quality of animal and human lives. Current traditional vaccines came empirically with either vague or completely no knowledge of how they modulate our immune system. Even at the face of potential vaccine design advance, immune-related concerns (as seen with specific vulnerable populations, cases of emerging/re-emerging infectious disease, pathogens with complex lifecycle and antigenic variability, need for personalized vaccinations, and concerns for vaccines' immunological safety -specifically vaccine likelihood to trigger non-antigen-specific responses that may cause autoimmunity and vaccine allergy) are being raised. And these concerns have driven immunologists toward research for a better approach to vaccine design that will consider these challenges. Currently, immunoinformatics has paved the way for a better understanding of some infectious disease pathogenesis, diagnosis, immune system response and computational vaccinology. The importance of this immunoinformatics in the study of infectious diseases is diverse in terms of computational approaches used, but is united by common qualities related to host-pathogen relationship. Bioinformatics methods are also used to assign functions to uncharacterized genes which can be targeted as a candidate in vaccine design and can be a better approach toward the inclusion of women that are pregnant into vaccine trials and programs. The essence of this review is to give insight into the need to focus on novel computational, experimental and computation-driven experimental approaches for studying of host-pathogen interactions and thus making a case for its use in vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
Doytchinova, I. A., & Flower, D. R. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-4 · Cited by 2,983
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Evolution of the immune system in humans from infancy to old age
Simon, A. K., Hollander, G. A., & McMichael, A. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.3085 · Cited by 1,796
The twilight of immunity: emerging concepts in aging of the immune system
Nikolich-Žugich, J. (2018) · Nature Immunology · doi:10.1038/s41590-017-0006-x · Cited by 1,240
PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex
Lamiable, A., Thévenet, P., Rey, J., Vavrusa, M., Derreumaux, P., & Tufféry, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw329 · Cited by 1,053
Manzoni, C., Kia, D. A., Vandrovcova, J., Hardy, J., Wood, N. W., Lewis, P. A., & Ferrari, R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbw114 · Cited by 804
Pneumococcal Capsules and Their Types: Past, Present, and Future
Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., Konradsen, H. B., & Nahm, M. H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-15 · Cited by 732
Brodin, P., & Davis, M. M. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2016.125 · Cited by 730
Neoantigen vaccine: an emerging tumor immunotherapy
Peng, M., Mo, Y., Wang, Y., Wu, P., Zhang, Y., Xiong, F., Guo, C., Wu, X., Li, Y., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1055-6 · Cited by 700
Fundamentals and Methods for T- and B-Cell Epitope Prediction
Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/2680160 · Cited by 674
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
Blackwell, J. M., Jamieson, S. E., & Burgner, D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-08 · Cited by 505
Whole-Genome Sequencing of Bacterial Pathogens: the Future of Nosocomial Outbreak Analysis
Quainoo, S., Coolen, J. P. M., van Hijum, S. A. F. T., Huynen, M. A., Melchers, W. J. G., van Schaik, W., & Wertheim, H. F. L. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-17 · Cited by 458
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.003 · Cited by 445
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 435
The Pneumococcus: Epidemiology, Microbiology, and Pathogenesis
Henriques-Normark, B., & Tuomanen, E. I. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010215 · Cited by 411
Sex differences in vaccine-induced humoral immunity
Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H., & Alter, G. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0726-5 · Cited by 410
Prediction of MHC class I binding peptides using profile motifs
Reche, P. A., Glutting, J.-P., & Reinherz, E. L. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00432-9 · Cited by 375
Shey, R. A., Ghogomu, S. M., Esoh, K. K., Nebangwa, N. D., Shintouo, C. M., Nongley, N. F., Asa, B. F., Ngale, F. N., Vanhamme, L., & Souopgui, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40833-x · Cited by 362
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 360
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
The consequences of human actions on risks for infectious diseases: a review
Lindahl, J. F., & Grace, D. (2015) · Infection Ecology & Epidemiology · doi:10.3402/iee.v5.30048 · Cited by 353
Ibáñez de Aldecoa, A. L., Zafra, O., & González-Pastor, J. E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01390 · Cited by 310
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
Atsaves, V., Leventaki, V., Rassidakis, G. Z., & Claret, F. X. (2019) · Cancers · doi:10.3390/cancers11071037 · Cited by 293
Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
Palm, A.-K. E., & Henry, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01787 · Cited by 288
The Protein Model Portal—a comprehensive resource for protein structure and model information
Haas, J., Roth, S., Arnold, K., Kiefer, F., Schmidt, T., Bordoli, L., & Schwede, T. (2013) · Database · doi:10.1093/database/bat031 · Cited by 268
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.040 · Cited by 267
Biological sex affects vaccine efficacy and protection against influenza in mice
Fink, A. L., Engle, K., Ursin, R. L., Tang, W.-Y., & Klein, S. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805268115 · Cited by 253
Bioinformatics and Drug Discovery
Xia, X. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666161116143440 · Cited by 252
Crux, N. B., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00832 · Cited by 239
New technologies in predicting, preventing and controlling emerging infectious diseases
Christaki, E. (2015) · Virulence · doi:10.1080/21505594.2015.1040975 · Cited by 226
Piasecka, B., Duffy, D., Urrutia, A., Quach, H., Patin, E., Posseme, C., Bergstedt, J., Charbit, B., Rouilly, V., MacPherson, C. R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714765115 · Cited by 213
Saadi, M., Karkhah, A., & Nouri, H. R. (2017) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2017.04.009 · Cited by 210
Towards a universal influenza vaccine: different approaches for one goal
Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 201
Chauhan, V., Rungta, T., Goyal, K., & Singh, M. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-39299-8 · Cited by 195
From genome to vaccine: in silico predictions, ex vivo verification
De Groot, A. S., Bosma, A., Chinai, N., Frost, J., Jesdale, B. M., Gonzalez, M. A., Martin, W., & Saint-Aubin, C. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00145-1 · Cited by 175
Pneumococcal Vaccination Strategies. An Update and Perspective
Berical, A. C., Harris, D., Dela Cruz, C. S., & Possick, J. D. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201511-778fr · Cited by 175
Vaccinations for Pregnant Women
Swamy, G. K., & Heine, R. P. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000581 · Cited by 174
Adhikari, U. K., Tayebi, M., & Rahman, M. M. (2018) · Journal of Immunology Research · doi:10.1155/2018/6718083 · Cited by 174
Omer, S. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509044 · Cited by 173
Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
Gfeller, D., & Bassani-Sternberg, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01716 · Cited by 170
Krubiner, C. B., Faden, R. R., Karron, R. A., Little, M. O., Lyerly, A. D., Abramson, J. S., Beigi, R. H., Cravioto, A. R., Durbin, A. P., Gellin, B. G., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2019.01.011 · Cited by 169
Vaccines for the elderly: current use and future challenges
Weinberger, B. (2018) · Immunity & Ageing · doi:10.1186/s12979-017-0107-2 · Cited by 160
Bühler, S., & Sanchez‐Mazas, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014643 · Cited by 156
Adaptive immune responses mediated by natural killer cells
Paust, S., Senman, B. C., & von Andrian, U. H. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00906.x · Cited by 154
Antigenic Variation in Plasmodium falciparum Malaria Involves a Highly Structured Switching Pattern
Recker, M., Buckee, C. O., Serazin, A. C., Kyes, S., Pinches, R. A., Christodoulou, Z., Springer, A., Gupta, S., & Newbold, C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001306 · Cited by 145
Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites
Belachew, E. B. (2018) · Journal of Immunology Research · doi:10.1155/2018/6529681 · Cited by 143
Maternal immunization: where are we now and how to move forward?
Vojtek, I., Dieussaert, I., Doherty, T. M., Franck, V., Hanssens, L., Miller, J. M., Bekkat-Berkani, R., Kandeil, W., Prado-Cohrs, D., & Vyse, A. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1421320 · Cited by 139
New approaches to understanding the immune response to vaccination and infection
Furman, D., & Davis, M. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.117 · Cited by 136
Evolution and emergence of infectious diseases in theoretical and real-world networks
Leventhal, G. E., Hill, A. L., Nowak, M. A., & Bonhoeffer, S. (2015) · Nature Communications · doi:10.1038/ncomms7101 · Cited by 133
Burton, D. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030262 · Cited by 132
Bahrami, A. A., Payandeh, Z., Khalili, S., Zakeri, A., & Bandehpour, M. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1657426 · Cited by 132
NERVE: New Enhanced Reverse Vaccinology Environment
Vivona, S., Bernante, F., & Filippini, F. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-35 · Cited by 130
Major histocompatibility complex class I binding predictions as a tool in epitope discovery
Lundegaard, C., Lund, O., Buus, S., & Nielsen, M. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03300.x · Cited by 126
Novel approaches for the design, delivery and administration of vaccine technologies
Wallis, J., Shenton, D. P., & Carlisle, R. C. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13287 · Cited by 123
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
Clemens, E. B., van de Sandt, C. E., Wong, S., Wakim, L. M., & Valkenburg, S. A. (2018) · Vaccines · doi:10.3390/vaccines6020018 · Cited by 123
Collineau, L., Boerlin, P., Carson, C. A., Chapman, B., Fazil, A., Hetman, B. M., McEwen, S. A., Parmley, E. J., Reid‐Smith, R. J., Taboada, E. N., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01107 · Cited by 121
Naz, K., Naz, A., Ashraf, S. T., Rizwan, M., Ahmad, J., Baumbach, J., & Ali, A. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2713-9 · Cited by 116
Progress and challenges in TB vaccine development
Voss, G., Casimiro, D. R., Neyrolles, O., Williams, A., Kaufmann, S. H. E., McShane, H., Hatherill, M., & Fletcher, H. A. (2018) · F1000Research · doi:10.12688/f1000research.13588.1 · Cited by 114
Computational approaches for prediction of pathogen-host protein-protein interactions
Nouranı, E., Khunjush, F., & DurmuÅŸ, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00094 · Cited by 113
Complex immune correlates of protection in HIV ‐1 vaccine efficacy trials
Tomaras, G. D., & Plotkin, S. A. (2017) · Immunological Reviews · doi:10.1111/imr.12514 · Cited by 113
Poland, G. A., Kennedy, R. B., & Ovsyannikova, I. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002344 · Cited by 109
Moise, L., Gutiérrez, A. H., Kibria, F., Martin, R., Tassone, R., Liu, R., Terry, F. E., Martin, B., & Groot, A. S. D. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1061159 · Cited by 108
Novel Platforms for the Development of a Universal Influenza Vaccine
Kumar, A., Meldgaard, T. S., & Bertholet, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00600 · Cited by 107
Biochemical functional predictions for protein structures of unknown or uncertain function
Mills, C. L., Beuning, P. J., & Ondrechen, M. J. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.02.003 · Cited by 102
Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model
Jiang, P., Cai, Y., Chen, J., Ye, X., Mao, S., Zhu, S., Xue, X., Chen, S., & Zhang, L. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.031 · Cited by 101
Rizwan, M., Naz, A., Ahmad, J., Naz, K., Obaid, A., Parveen, T., Ahsan, M. H., & Ali, A. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1540-0 · Cited by 100
The emerging influenza virus threat: status and new prospects for its therapy and control
Kumar, B., Asha, K., Khanna, M., Ronsard, L., Meseko, C. A., & Sanicas, M. (2018) · Archives of Virology · doi:10.1007/s00705-018-3708-y · Cited by 100
Antigenic Variation in Bacterial Pathogens
Palmer, G. H., Bankhead, T., & Seifert, H. S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0005-2015 · Cited by 93
HIV vaccine development by computer assisted design: the GAIA vaccine
Groot, A. S. D., Marcon, L., Bishop, E. A., Rivera, D. S., Kutzler, M. A., Weiner, D. B., & Martin, W. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.097 · Cited by 88
Jaiswal, V., Chanumolu, S. K., Gupta, A. R., Chauhan, R. S., & Rout, C. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-211 · Cited by 86
Furuta, M., Sin, J., Ng, E. S. W., & Wang, K. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1559-2 · Cited by 83
Sex Differences in Older Adults' Immune Responses to Seasonal Influenza Vaccination
Voigt, E. A., Ovsyannikova, I. G., Kennedy, R. B., Grill, D. E., Goergen, K. M., Schaid, D. J., & Poland, G. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00180 · Cited by 82
Xiang, Z., & He, Y. O. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s4-s2 · Cited by 80
Systems vaccinology and big data in the vaccine development chain
Raeven, R. H. M., van Riet, E., Meiring, H. D., Metz, B., & Kersten, G. F. A. (2018) · Immunology · doi:10.1111/imm.13012 · Cited by 79
Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses
Auladell, M. A., Jia, X., Hensen, L., Chua, B. Y. L., Fox, A., Nguyen, T. H. O., Doherty, P. C., & Kedzierska, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01400 · Cited by 79
Imle, A., Kumberger, P., Schnellbächer, N. D., Fehr, J., Carrillo-Bustamante, P., Ales, J., Schmidt, P., Ritter, C., Godinez, W. J., Müller, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09879-3 · Cited by 76
Global practices of meningococcal vaccine use and impact on invasive disease
Ali, A., Jafri, R. Z., Messonnier, N. E., Tévi‐Bénissan, C., Dürrheim, D. N., Eskola, J., Fermon, F., Klugman, K. P., Ramsay, M. E., Sow, S. O., et al. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000126 · Cited by 72
Hensley, S. E., Das, S. R., Gibbs, J. S., Bailey, A. L., Schmidt, L. M., Bennink, J. R., & Yewdell, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015190 · Cited by 72
From Entry to Early Dissemination—Toxoplasma gondii's Initial Encounter With Its Host
Betancourt, E. D., Hamid, B., Fabian, B. T., Klotz, C., Hartmann, S., & Seeber, F. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00046 · Cited by 72
A Review of the Immunological Mechanisms Following Mucosal Vaccination of Finfish
Munang’andu, H. M., Mutoloki, S., & Evensen, Ø. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00427 · Cited by 70
Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against Helicobacter pylori
Urrutia-Baca, V. H., Gomez‐Flores, R., la Garza-Ramos, M. A. D., Tamez‐Guerra, P., Lucio-sauceda, D. G., & Rodríguez-padilla, M. C. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0062 · Cited by 70
Dadar, M., Chakraborty, S., Dhama, K., Prasad, M., Khandia, R., Hassan, S., Munjal, A. K., Tiwari, R., Karthik, K., Kumar, D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02478 · Cited by 68
How Does the VSG Coat of Bloodstream Form African Trypanosomes Interact with External Proteins?
Schwede, A., Macleod, O. J. S., MacGregor, P., & Carrington, M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005259 · Cited by 67
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes
Moise, L., McMurry, J. A., Buus, S., Frey, S. E., Martin, W. D., & Groot, A. S. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.018 · Cited by 66
Pinger, J., Chowdhury, S., & Papavasiliou, F. N. (2017) · Nature Communications · doi:10.1038/s41467-017-00959-w · Cited by 66
Lu, I., Farinelle, S., Sausy, A., & Muller, C. P. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.20 · Cited by 64
Ebola Virus Disease in Pregnancy: Clinical, Histopathologic, and Immunohistochemical Findings
Muehlenbachs, A., Vázquez, O. D. L. R., Bausch, D. G., Schafer, I. J., Paddock, C. D., Nyakio, J.-P., Lame, P., Bergeron, É., McCollum, A. M., Goldsmith, C. S., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw206 · Cited by 64
Mhondoro, M., Ndlovu, N., Bangure, D., Juru, T., Gombe, N. T., Shambira, G., Nsubuga, P., & Tshimanga, M. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4295-6 · Cited by 61
He, R., Yang, X., Liu, C., Chen, X., Wang, L., Xiao, M., Ye, J., Wu, Y., & Ye, L. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.3 · Cited by 59
Innovation for the ‘Bottom 100 Million’: Eliminating Neglected Tropical Diseases in the Americas
Hotez, P. J., Dumonteil, E., Heffernan, M. J., & Bottazzi, M. E. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4726-9_1 · Cited by 58
Designing string-of-beads vaccines with optimal spacers
Schubert, B., & Kohlbacher, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0263-6 · Cited by 56
In Silico Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein
Zheng, J., Lin, X., Wang, X., Zheng, L., Lan, S., Jin, S., Ou, Z., & Wu, J. (2017) · Viruses · doi:10.3390/v9050112 · Cited by 56
Large screen approaches to identify novel malaria vaccine candidates
Davies, D. H., Duffy, P. E., Bodmer, J.-L., Felgner, P. L., & Doolan, D. L. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.059 · Cited by 55
Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets
Servín-Blanco, R., Zamora-Alvarado, R., Gevorkian, G., & Manoutcharian, K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1191718 · Cited by 55
Vaccination to gain humoral immune memory
Sarkander, J., Hojyo, S., & Tokoyoda, K. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.81 · Cited by 51
Vaccination With Sporozoites: Models and Correlates of Protection
Goh, Y. S., McGuire, D., & Rénia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01227 · Cited by 51
Bachmann, A., Bruske, E. I., Krumkamp, R., Turner, L., Wichers-Misterek, J. S., Petter, M., Held, J., Duffy, M. F., Sim, B. K. L., Hoffman, S. L., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007906 · Cited by 51
Molineros, J., Looger, L., Kim, K., Okada, Y., Terao, C., Sun, C.-L., Zhou, X.-J., Raj, P., Kochi, Y., Suzuki, A., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008092 · Cited by 50
Rodrigues, T. C. V., Jaiswal, A. K., Sarom, A. D., Oliveira, L. D. C., Oliveira, C. J. F., Ghosh, P., Tiwari, S., Miranda, F. M., Benevides, L. D. J., Azevedo, V., et al. (2019) · Royal Society Open Science · doi:10.1098/rsos.190907 · Cited by 50
Utesch, T., Catalina, A. D. M., Schattenberg, C. J., Paege, N., Schmieder, P., Krause, E., Miao, Y., McCammon, J. A., Meyer, V., Jung, S., et al. (2018) · mSphere · doi:10.1128/msphere.00377-18 · Cited by 49
Major histocompatibility complex: Antigen processing and presentation
Cruz‐Tapias, P., Castiblanco, J., & Anaya, J. (2013) · Cited by 49
Proteomics for development of vaccine
Adamczyk-Popławska, M., Markowicz, S., & Jagusztyn-Krynicka, E. K. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.019 · Cited by 48
Benavente, E. D., Oresegun, D. R., de Sessions, P. F., Walker, E. M., Roper, C., Dombrowski, J. G., de Souza, R. M., Marinho, C. R. F., Sutherland, C. J., Hibberd, M. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33767-3 · Cited by 47
Terry, F. E., Moise, L., Martin, R., Torres, M., Pilotte, N., Williams, S. A., & Groot, A. S. D. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.955478 · Cited by 46
Genomic characterization of novel Neisseria species
Diallo, K., MacLennan, J. M., Harrison, O. B., Msefula, C. L., Sow, S. O., Daugla, D. M., Johnson, E., Trotter, C. L., MacLennan, C. A., Parkhill, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50203-2 · Cited by 44
Antigenic Variation and Immune Escape in the MTBC
Ernst, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-64371-7_9 · Cited by 42
Hermand, P., Cicéron, L., Pionneau, C., Vaquero, C., Combadière, C., & Déterre, P. (2016) · Scientific Reports · doi:10.1038/srep33786 · Cited by 40
Mobile genetic elements in Neisseria gonorrhoeae: movement for change
Cehovin, A., & Lewis, S. B. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx071 · Cited by 39
The use of databases, data mining and immunoinformatics in vaccinology: where are we?
Hegde, N. R., Gauthami, S., Kumar, H. M. S., & Bayry, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1413088 · Cited by 39
Cotugno, N., Ruggiero, A., Santilli, V., Manno, E. C., Rocca, S., Zicari, S., Amodio, D., Colucci, M., Rossi, P., Levy, O., et al. (2019) · Journal of Immunology Research · doi:10.1155/2019/8732191 · Cited by 39
Kaifu, T., & Nakamura, A. (2017) · International Immunology · doi:10.1093/intimm/dxx041 · Cited by 38
Sampaio, N. G., Eriksson, E. M., & Schofield, L. (2017) · Infection and Immunity · doi:10.1128/iai.00447-17 · Cited by 38
Vaccinology in the third millennium: scientific and social challenges
Poland, G. A., Whitaker, J. A., Poland, C. M., Ovsyannikova, I. G., & Kennedy, R. B. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.003 · Cited by 37
Wilcox, C. R., & Jones, C. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01548 · Cited by 36
Expression of the Plasmodium falciparum Clonally Variant clag3 Genes in Human Infections
Mira-Martínez, S., van Schuppen, E., Amambua‐Ngwa, A., Bottieau, E., Affara, M., Esbroeck, M. V., Vlieghe, E., Guetens, P., Rovira‐Graells, N., Gómez-Pérez, G. P., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix053 · Cited by 35
Kaliamurthi, S., Selvaraj, G., Kaushik, A. C., Gu, K., & Wei, D. (2018) · Biologics · doi:10.2147/btt.s177901 · Cited by 32
Michalik, M., Djahanschiri, B., Leo, J. C., & Linke, D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_4 · Cited by 30
Abdi, A. I., Hodgson, S. H. C., Muthui, M. K., Andisi, C., Kamuyu, G., Kimani, D., Hoffman, S. L., Juma, E. A., Ogutu, B. R., Draper, S. J., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2686-0 · Cited by 30
Predicting HLA Class I Non-Permissive Amino Acid Residues Substitutions
Binkowski, T. A., Marino, S. R., & Joachimiak, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041710 · Cited by 29
Neisseria genomics: current status and future perspectives
Harrison, O. B., Schoen, C. U., Retchless, A. C., Wang, X., Jolley, K. A., Bray, J. E., & Maiden, M. C. J. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx060 · Cited by 29
Jeppesen, A., Ditlev, S. B., Soroka, V., Stevenson, L., Turner, L., Dzikowski, R., Hviid, L., & Barfod, L. K. (2015) · Infection and Immunity · doi:10.1128/iai.00337-15 · Cited by 27
A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta
Fonseca, L. L., Joyner, C. J., Galinski, M. R., & Voit, E. O. (2017) · Malaria Journal · doi:10.1186/s12936-017-2008-4 · Cited by 26
Singh, S. P., Srivastava, D., & Mishra, B. N. (2017) · 3 Biotech · doi:10.1007/s13205-017-0947-7 · Cited by 25
Dittmer, U., Sutter, K., Kassiotis, G., Zelinskyy, G., Bánki, Z., Stoiber, H., Santiago, M. L., & Hasenkrug, K. J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz012 · Cited by 25
Oli, A. N., Agu, R. U., Ihekwereme, C. P., & Esimone, C. O. (2017) · Pan African Medical Journal · doi:10.11604/pamj.supp.2017.27.3.11491 · Cited by 19
Self-citationHossain, M. U., Omar, T. M., Oany, A. R., Kibria, K. M. K., Shibly, A. Z., Moniruzzaman, M., Ali, S. R., & Islam, M. M. (2018) · 3 Biotech · doi:10.1007/s13205-018-1106-5 · Cited by 19
Computational Approaches and Challenges to Developing Universal Influenza Vaccines
Qiu, X., Duvvuri, V. R. S. K., & Bahl, J. (2019) · Vaccines · doi:10.3390/vaccines7020045 · Cited by 19
Zika Virus Epidemic in Pregnant Women, Dominican Republic, 2016–2017
Peña, F., Pimentel, R., Khosla, S., Mehta, S. D., & Brito, M. O. (2019) · Emerging infectious diseases · doi:10.3201/eid2502.181054 · Cited by 14
Nnamdi, O. A., Agu, R. U., Chinedum, O. U., Nwoye, C. U., Ejiofor, O. S., & Okechukwu, E. C. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30157-x · Cited by 13
Mboowa, G., Sserwadda, I., Amujal, M., & Namatovu, N. (2018) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2018/1875217 · Cited by 12
Miller, S. E., Bell, C. S., McClain, M. S., Cover, T. L., & Giorgio, T. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163167 · Cited by 10
Mottram, L., Chakraborty, S., Cox, E., & Fleckenstein, J. M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.016 · Cited by 9
Advances in genetics and genomics: use and limitations in achieving malaria elimination goals
Gunawardena, S., & Karunaweera, N. D. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000015 · Cited by 8
Gangnard, S., Chêne, A., Dechavanne, S., Srivastava, A., Avril, M., Smith, J. D., & Gamain, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-53334-8 · Cited by 8
Development of a human leukocyte antigen-based HIV vaccine
Wang, Y. (2018) · F1000Research · doi:10.12688/f1000research.13759.1 · Cited by 4
Cited by
Just Keep Rolling?—An Encompassing Review towards Accelerated Vaccine Product Life Cycles
(2023) · doi:10.3390/vaccines11081287 · Cited by 11
Yang, Y., Xue, Y., Wang, X., Wang, L., Wang, J., Zhang, J., Liu, Y., Liang, Y., & Wu, X. (2024) · Immunity, Inflammation and Disease · doi:10.1002/iid3.70074 · Cited by 2
Metadata
- Authors
- Oli, A. N., Obialor, W. O., Ifeanyichukwu, M. O., Odimegwu, D. C., Okoyeh, J. N., Emechebe, G. O., Adejumo, S. A., & Ibeanu, G. C.
- Venue
- ImmunoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-02
- Volume
- Volume 9
- Pages
- 13-30
- ISSN
- 2253-1556 (ISSN-L)
- OpenAlex
- W3007680806
- Cited by
- 281
- References
- 136
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.